New 20-Valent pneumonia vaccine shows promise in chinese seniors
NCT ID NCT07019909
First seen Nov 21, 2025 · Last updated May 25, 2026 · Updated 28 times
Summary
This study tested a new vaccine (20vPnC) that protects against 20 types of pneumonia-causing bacteria. It involved 400 Chinese adults aged 50 and older who had never received a pneumonia vaccine. Researchers compared the new vaccine's safety and immune response to an existing 13-valent vaccine. The goal is to see if the broader protection is safe and effective for this age group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PNEUMOCOCCAL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kaihua County Center For Disease Prevention and Control
Kaihua, Zhejiang, 324300, China
-
Kaihua County Center For Disease Prevention and Control
Quzhou, Zhejiang, 324300, China
-
Zhejiang provincial center for disease control and prevention
Hangzhou, Zhejiang, 310051, China
Conditions
Explore the condition pages connected to this study.